Andrew Rees, the Chief Executive Officer of $CROX, sold 6,900 shares of the company on 06-05-2026 for an estimated $807,094. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.9% of their shares of this class of stock. Following this trade, they now own 769,081 shares of this class of $CROX stock.
$CROX Insider Trading Activity
$CROX insiders have traded $CROX stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $CROX stock by insiders over the last 6 months:
- ANDREW REES (Chief Executive Officer) has made 0 purchases and 3 sales selling 32,688 shares for an estimated $3,860,284.
- ANNE MEHLMAN (EVP & Crocs Brand President) sold 12,145 shares for an estimated $1,215,171
- THOMAS J SMACH has made 0 purchases and 2 sales selling 9,963 shares for an estimated $988,370.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CROX Hedge Fund Activity
We have seen 227 institutional investors add shares of $CROX stock to their portfolio, and 303 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DME CAPITAL MANAGEMENT, LP added 669,140 shares (+inf%) to their portfolio in Q1 2026, for an estimated $55,552,002
- D. E. SHAW & CO., INC. added 634,532 shares (+9592.3%) to their portfolio in Q4 2025, for an estimated $54,265,176
- INVESCO LTD. removed 593,720 shares (-77.4%) from their portfolio in Q4 2025, for an estimated $50,774,934
- MORGAN STANLEY removed 546,235 shares (-46.5%) from their portfolio in Q1 2026, for an estimated $45,348,429
- FMR LLC removed 477,236 shares (-11.3%) from their portfolio in Q1 2026, for an estimated $39,620,132
- CITADEL ADVISORS LLC removed 471,588 shares (-46.7%) from their portfolio in Q1 2026, for an estimated $39,151,235
- PACER ADVISORS, INC. removed 461,496 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $39,467,137
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CROX Revenue
$CROX had revenues of $921.5M in Q1 2026. This is a decrease of -1.69% from the same period in the prior year.
You can track CROX financials on Quiver Quantitative's CROX stock page.
You can access data on CROX stock through the Quiver Quantitative API.
$CROX Price Targets
Multiple analysts have issued price targets for $CROX recently. We have seen 8 analysts offer price targets for $CROX in the last 6 months, with a median target of $121.0.
Here are some recent targets:
- Jonathan Komp from Baird set a target price of $150.0 on 06/08/2026
- Christopher Nardone from B of A Securities set a target price of $145.0 on 06/04/2026
- Adrienne Yih from Barclays set a target price of $110.0 on 05/01/2026
- Jay Sole from UBS set a target price of $107.0 on 05/01/2026
- Tom Nikic from Needham set a target price of $132.0 on 04/21/2026
- Mitch Kummetz from Seaport Global set a target price of $135.0 on 04/14/2026
- Brooke Roach from Goldman Sachs set a target price of $81.0 on 02/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
